Enochian Biosciences Gene Cell Therapies 2022

Enochian Biosciences presents enhanced gene and cell therapy platform designed to harness immune response against cancer and infectious diseases. The company, Nasdaq-listed (ENOB) and headquartered in Los Angeles, outlines its clinical pipeline, funding status ($75M raised to date), and strategic positioning in immunotherapy development.